Resolute Integrity Zotarolimus-Eluting Coronary Stent Systems
FDA premarket approval P110013/S080 · decided 2017-10-04
Approval details
- PMA number
- P110013
- Supplement
- S080
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Resolute Integrity Zotarolimus-Eluting Coronary Stent Systems
- Generic name
- Coronary drug-eluting stent
- Applicant
- Medtronic Vascular
- Date received
- 2017-07-03
- Decision date
- 2017-10-04
- Days to decision
- 93 days
- Decision code
- APPR
- Product code
- NIQ
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Santa Rosa, CA
- Statement
- Approval for a material change to the distal inner shaft of the Resolute Integrity Zotarolimus-Eluting Coronary Stent Systems (RX & OTW).
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.